Structural and Functional Recovery Following Limited Iatrogenic Macular Detachment for Retinal Gene Therapy
- PMID: 28152124
- DOI: 10.1001/jamaophthalmol.2016.5630
Structural and Functional Recovery Following Limited Iatrogenic Macular Detachment for Retinal Gene Therapy
Abstract
Importance: The early decline and recovery of retinal structure and function following iatrogenic macular detachment for retinal gene therapy is not well characterized in those with relatively preserved central visual function. Here, the recovery of retinal structure and function over the first month following iatrogenic retinal detachment for the delivery of adeno-associated viral vector encoding Rab Escort Protein 1 is described as a part of gene therapy for choroideremia.
Objective: To study changes in both retinal structure and function during the first month following iatrogenic macular detachment surgery.
Design, setting, and participants: This prospective interocularly controlled study was conducted between February 1 and December 31, 2015. Treatment consisted of a subretinal injection of 0.1 mL of a gene therapy solution containing 1 × 1011 viral particles performed unilaterally. The participants were 5 males, aged 23 to 71 years, with a clinical and genetic diagnosis of choroideremia.
Main outcomes and measures: Retinal structure and function were assessed at baseline, 1 week, and 1 month using optical coherence tomography, logMAR visual acuity, microperimetry, the Farnsworth-Munsell (FM) 100-hue test, and the Rayleigh match.
Results: Five white male patients aged 23 to 71 years underwent unilateral subretinal gene therapy for genetically confirmed choroidermeia. Optical coherence tomographic images demonstrated a complete resolution of the resulting iatrogenic retinal detachment by 1 week in all 5 patients. At 1 month, the mean (SE) change in central foveal thickness was +9.6 (7.2) μm in treated eyes and +8.8 (12.6) μm in control eyes. The mean (SE) change in visual acuity was +5.4 (3.3) letters in treated eyes and +0.8 (3.1) letters in control eyes. At 1 month, the mean (SE) threshold sensitivity changes were -1.2 (2.1) dB in treated eyes and -1.0 (1.2) dB in control eyes. Color discrimination at the FM 100-hue changed little at 1 month (mean [SE] change in C-index, -0.2 [0.4] in treated eyes and 0.1 [0.2] in control eyes). Rayleigh matches in 1 patient were consistent with a diagnosis of pseudoprotanomaly, suggesting decreased effective optical density of the cone photopigments.
Conclusions and relevance: Retinal structural recovery-as assessed by optical coherence tomography-occurs soon after iatrogenic detachment. Similarly, visual acuity recovers or improves within 1 month of the procedure and may not be accompanied by improvements in threshold sensitivity or color discrimination. Changes in color matching in 1 patient suggest decreased optical density of the cone photopigments in the early postoperative period.
Comment in
-
Visual Consequences of Delivering Therapies to the Subretinal Space.JAMA Ophthalmol. 2017 Mar 1;135(3):242-243. doi: 10.1001/jamaophthalmol.2016.5659. JAMA Ophthalmol. 2017. PMID: 28152125 No abstract available.
-
Using Rho Kinase Inhibitors for Retinal Detachment.JAMA Ophthalmol. 2017 Aug 1;135(8):895. doi: 10.1001/jamaophthalmol.2017.2276. JAMA Ophthalmol. 2017. PMID: 28715522 No abstract available.
-
Using Rho Kinase Inhibitors for Retinal Detachment-Reply.JAMA Ophthalmol. 2017 Aug 1;135(8):895-896. doi: 10.1001/jamaophthalmol.2017.2283. JAMA Ophthalmol. 2017. PMID: 28715526 No abstract available.
Similar articles
-
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.Lancet. 2014 Mar 29;383(9923):1129-37. doi: 10.1016/S0140-6736(13)62117-0. Epub 2014 Jan 16. Lancet. 2014. PMID: 24439297 Free PMC article. Clinical Trial.
-
Technique of retinal gene therapy: delivery of viral vector into the subretinal space.Eye (Lond). 2017 Sep;31(9):1308-1316. doi: 10.1038/eye.2017.158. Epub 2017 Aug 18. Eye (Lond). 2017. PMID: 28820183 Free PMC article.
-
Gene therapy for choroideremia using an adeno-associated viral vector encoding Rab escort protein 1: the REGENERATE open-label trial.Southampton (UK): National Institute for Health and Care Research; 2024 May. Southampton (UK): National Institute for Health and Care Research; 2024 May. PMID: 38870335 Free Books & Documents. Review.
-
Visual recovery after scleral buckling for macula-off retinal detachments: an optical coherence tomography study.Eur J Ophthalmol. 2007 Sep-Oct;17(5):790-6. doi: 10.1177/112067210701700517. Eur J Ophthalmol. 2007. PMID: 17932857
-
Microstructural and hemodynamic changes in the fundus after pars plana vitrectomy for different vitreoretinal diseases.Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):1977-1992. doi: 10.1007/s00417-023-06303-x. Epub 2023 Nov 20. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37982887 Review.
Cited by
-
Choroideremia: The Endpoint Endgame.Int J Mol Sci. 2023 Sep 20;24(18):14354. doi: 10.3390/ijms241814354. Int J Mol Sci. 2023. PMID: 37762657 Free PMC article. Review.
-
Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis.Transl Vis Sci Technol. 2023 Nov 1;12(11):24. doi: 10.1167/tvst.12.11.24. Transl Vis Sci Technol. 2023. PMID: 37982768 Free PMC article.
-
How Advanced are Nanocarriers for Effective Subretinal Injection?Int J Nanomedicine. 2024 Sep 10;19:9273-9289. doi: 10.2147/IJN.S479327. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39282576 Free PMC article. Review.
-
ROCK inhibition reduces morphological and functional damage to rod synapses after retinal injury.Sci Rep. 2021 Jan 12;11(1):692. doi: 10.1038/s41598-020-80267-4. Sci Rep. 2021. PMID: 33436892 Free PMC article.
-
Assessing Photoreceptor Status in Retinal Dystrophies: From High-Resolution Imaging to Functional Vision.Am J Ophthalmol. 2021 Oct;230:12-47. doi: 10.1016/j.ajo.2021.04.013. Epub 2021 May 14. Am J Ophthalmol. 2021. PMID: 34000280 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous